Search results
Results from the WOW.Com Content Network
[citation needed] Also by then, "a wave of recalls" had taken place. [21] Some of the lawsuits, which by October 2021 included over 100,000 plaintiffs, [5] were filed due to impending statute of limitations laws; estimates of how many people used Zantac have been given as high as 15 million. [citation needed] Facets of the legal rangling included:
Sanofi discontinued the ranitidine formulation of Zantac, and the new formulation, Zantac 360, is made with a different active ingredient. Sanofi to settle 4,000 lawsuits claiming Zantac is linked ...
Ranitidine, previously sold under the brand name Zantac [a] among others, is a medication used to decrease stomach acid production. [12] It was commonly used in treatment of peptic ulcer disease, gastroesophageal reflux disease, and Zollinger–Ellison syndrome. [12] It can be given by mouth, injection into a muscle, or injection into a vein.
NEW YORK (Reuters) -Sanofi has reached an agreement in principle to settle 4,000 U.S. lawsuits linking the discontinued heartburn drug Zantac to cancer, the company said on Wednesday. Sanofi did ...
The FDA's advisory said people already taking Zantac, made by Sanofi, or generic forms of the antacid should stop and switch to other heartburn medications that do not contain ranitidine.
Zantac can refer to either of two different H 2 antagonists used to reduce gastric acid secretion: Ranitidine , prior to its 2020 withdrawal from the market Famotidine , following the withdrawal of ranitidine
The drugmaker has settled a series of lawsuits related to Zantac over the past 12 months, including several in California. California is generally seen as a more challenging legal environment for ...
Famotidine, sold under the brand name Pepcid among others, is a histamine H 2 receptor antagonist medication that decreases stomach acid production. [4] It is used to treat peptic ulcer disease , gastroesophageal reflux disease , and Zollinger-Ellison syndrome . [ 4 ]